Łaguna P - Search Results

1

Single higher dose of recombinant activated factor VII in the treatment of hemorrhages in patients with hemophilia complicated by inhibitors.

Łaguna P, Mital A. Łaguna P, et al. Adv Clin Exp Med. 2012 Jul-Aug;21(4):519-24. Adv Clin Exp Med. 2012. PMID: 23240458 Free article. Review.

2

Acquired factor VIII inhibitor in a non-haemophilic boy.

Klukowska A, Łaguna P, Obitko-Płudowska A, Niedzielska K, Malinowska I, Rokicka-Milewska R. Klukowska A, et al. Among authors: laguna p. Haemophilia. 2003 Sep;9(5):642-5. doi: 10.1046/j.1365-2516.2003.00797.x. Haemophilia. 2003. PMID: 14511308

3

Management of oral bleedings with recombinant factor VIIa in children with haemophilia A and inhibitor.

Laguna P, Klukowska A. Laguna P, et al. Haemophilia. 2005 Jan;11(1):2-4. doi: 10.1111/j.1365-2516.2005.01051.x. Haemophilia. 2005. PMID: 15660981 Review.

4

Intracranial haemorrhage in a boy with severe haemophilia A and factor VIII inhibitor.

Laguna P, Klukowska A. Laguna P, et al. Childs Nerv Syst. 2006 Apr;22(4):432-5. doi: 10.1007/s00381-005-1168-7. Epub 2005 Jun 1. Childs Nerv Syst. 2006. PMID: 15928966

5

Single-dose (270 microg kg(-1)) recombinant activated factor VII for the treatment and prevention of bleeds in haemophilia A patients with inhibitors: experience from seven European haemophilia centres.

Pan-Petesch B, Laguna P, Mital A, Stanley J, Torchet MF, Salek SZ, Salaj P. Pan-Petesch B, et al. Among authors: laguna p. Haemophilia. 2009 May;15(3):760-5. doi: 10.1111/j.1365-2516.2008.01968.x. Epub 2009 Feb 27. Haemophilia. 2009. PMID: 19298382

6

Low incidence of factor VIII inhibitors in previously untreated patients during prophylaxis, on-demand treatment and surgical procedures, with Octanate®: interim report from an ongoing prospective clinical study.

Klukowska A, Komrska V, Jansen M, Laguna P. Klukowska A, et al. Among authors: laguna p. Haemophilia. 2011 May;17(3):399-406. doi: 10.1111/j.1365-2516.2010.02428.x. Epub 2010 Dec 1. Haemophilia. 2011. PMID: 21118334

7

Real-world outcomes with recombinant factor VIIa treatment of acute bleeds in haemophilia patients with inhibitors: results from the international ONE registry.

Chambost H, Santagostino E, Laffan M, Kavakli K; ONE Registry Steering Committee on behalf of the investigators. Chambost H, et al. Haemophilia. 2013 Jul;19(4):571-7. doi: 10.1111/hae.12140. Epub 2013 Apr 5. Haemophilia. 2013. PMID: 23557542

8

Immunoglobulins and their use in children.

Łaguna P, Gołębiowska-Staroszczyk S, Trzaska M, Grabarczyk M, Matysiak M. Łaguna P, et al. Adv Clin Exp Med. 2015 Jan-Feb;24(1):153-9. doi: 10.17219/acem/28626. Adv Clin Exp Med. 2015. PMID: 25923100 Free article. Review.

9

Use of rFVIIa in Preventing Recurrent Intra-articular Hemorrhages in a 15-Year-Old Patient With Glanzmann Thrombasthenia.

Laguna P. Laguna P. J Pediatr Hematol Oncol. 2021 Nov 1;43(8):e1120-e1123. doi: 10.1097/MPH.0000000000002105. J Pediatr Hematol Oncol. 2021. PMID: 33625096

10

Efficacy and safety of OCTANINE F in children with haemophilia B.

Klukowska A, Laguna P, Svirin P, Shiller E, Vdovin V. Klukowska A, et al. Among authors: laguna p. Haemophilia. 2008 May;14(3):531-8. doi: 10.1111/j.1365-2516.2008.01678.x. Epub 2008 Mar 18. Haemophilia. 2008. PMID: 18355266 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

367 results

Search Page

Filters